These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24929833)

  • 1. Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.
    Logan SL; Carpenter L; Leslie RS; Hunt KS; Garrett-Mayer E; Charles J; Nicholas JS
    J Autism Dev Disord; 2014 Nov; 44(11):2931-48. PubMed ID: 24929833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
    Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
    Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.
    Murray MJ
    Curr Psychiatry Rep; 2010 Oct; 12(5):382-8. PubMed ID: 20694583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
    Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
    Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychopharmacology of autism spectrum disorders].
    Poustka L; Banaschewski T; Poustka F
    Nervenarzt; 2011 May; 82(5):582-9. PubMed ID: 21484169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication use and polypharmacy in children with autism spectrum disorders.
    Spencer D; Marshall J; Post B; Kulakodlu M; Newschaffer C; Dennen T; Azocar F; Jain A
    Pediatrics; 2013 Nov; 132(5):833-40. PubMed ID: 24144704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.
    Murray ML; Hsia Y; Glaser K; Simonoff E; Murphy DG; Asherson PJ; Eklund H; Wong IC
    Psychopharmacology (Berl); 2014 Mar; 231(6):1011-21. PubMed ID: 23681164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of autism spectrum disorders.
    Benvenuto A; Battan B; Porfirio MC; Curatolo P
    Brain Dev; 2013 Feb; 35(2):119-27. PubMed ID: 22541665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?
    Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP
    Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders.
    Nicolson R; Castellanos FX
    J Autism Dev Disord; 2000 Oct; 30(5):461-2. PubMed ID: 11098884
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotropic Medication Adherence in Children and Adolescents.
    Verma S; Agrawal R
    South Med J; 2021 Jul; 114(7):388-394. PubMed ID: 34215889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC; Henry CA; McDougle CJ
    Harv Rev Psychiatry; 2014; 22(2):76-92. PubMed ID: 24614763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology of autism spectrum disorder: evidence and practice.
    Siegel M
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):957-73. PubMed ID: 23040909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.
    Pearson DA; Aman MG; Arnold LE; Lane DM; Loveland KA; Santos CW; Casat CD; Mansour R; Jerger SW; Ezzell S; Factor P; Vanwoerden S; Ye E; Narain P; Cleveland LA
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):284-91. PubMed ID: 22849541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autism spectrum disorders and health care expenditures: the effects of co-occurring conditions.
    Peacock G; Amendah D; Ouyang L; Grosse SD
    J Dev Behav Pediatr; 2012 Jan; 33(1):2-8. PubMed ID: 22157409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.